IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i3p2388-d1050359.html
   My bibliography  Save this article

Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

Author

Listed:
  • Vicente Pallarés-Carratalá

    (Health Surveillance Unit, Unión de Mutuas, 12004 Castellón de la Plana, Spain
    Department of Medicine, Universitat Jaume I, 12071 Castellón de la Plana, Spain)

  • Vivencio Barrios

    (Cardiology Department, H Ramón y Cajal, 28034 Madrid, Spain
    Department of Medicine, Alcala University, 28801 Madrid, Spain)

  • David Fierro-González

    (Armunia Health Centre, 24009 León, Spain)

  • Jose Polo-García

    (Casar de Cáceres Health Centre, 10190 Cáceres, Spain)

  • Sergio Cinza-Sanjurjo

    (Milladoiro Health Centre, 15895 Santiago de Compostela, Spain
    Instituto de Investigación de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
    Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares (CIBER-CV), 28029 Madrid, Spain)

Abstract

Objective: The aim of this study was to evaluate, through a survey, the opinion of primary care (PC) physicians on the magnitude of dyslipidemia and its degree of control in their clinical practice. Materials and methods: An ecological study was carried out, in which the physicians were invited to participate by means of an online letter. Data were collected at a single timepoint and were based only on the experience, knowledge, and routine clinical practice of the participating physician. Results: A total of 300 physicians answered the questionnaire and estimated the prevalence of dyslipidemia between 2% and 80%. They estimated that 23.5% of their patients were high-risk, 18.2% were very high-risk, and 14.4% had recurrent events in the last 2 years. The PC physicians considered that 61.5% of their patients achieved the targets set. The participants fixed the presence of side-effects to statins at 14%. The statin that was considered safest with regard to side-effects was rosuvastatin (69%). Conclusions: PC physicians in Spain perceive that the CVR of their patients is high. This, together with the overestimation of the degree of control of LDL-C, could justify the inertia in the treatment of lipids. Moreover, they perceive that one-sixth of the patients treated with statins have side-effects.

Suggested Citation

  • Vicente Pallarés-Carratalá & Vivencio Barrios & David Fierro-González & Jose Polo-García & Sergio Cinza-Sanjurjo, 2023. "Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study," IJERPH, MDPI, vol. 20(3), pages 1-11, January.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:3:p:2388-:d:1050359
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/3/2388/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/3/2388/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Grzegorz K. Jakubiak & Natalia Pawlas & Grzegorz Cieślar & Agata Stanek, 2021. "Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes," IJERPH, MDPI, vol. 18(22), pages 1-23, November.
    2. Grzegorz K. Jakubiak & Natalia Pawlas & Grzegorz Cieślar & Agata Stanek, 2020. "Chronic Lower Extremity Ischemia and Its Association with the Frailty Syndrome in Patients with Diabetes," IJERPH, MDPI, vol. 17(24), pages 1-17, December.
    3. Cristina Soriano-Maldonado & Adriana Lopez-Pineda & Domingo Orozco-Beltran & Jose A. Quesada & Jose L. Alfonso-Sanchez & Vicente Pallarés-Carratalá & Jorge Navarro-Perez & Vicente F. Gil-Guillen & Jos, 2021. "Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO," IJERPH, MDPI, vol. 18(23), pages 1-14, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alexandru Achim & Agata Stanek & Călin Homorodean & Mihail Spinu & Horea Laurenţiu Onea & Leontin Lazăr & Mădălin Marc & Zoltán Ruzsa & Dan Mircea Olinic, 2022. "Approaches to Peripheral Artery Disease in Diabetes: Are There Any Differences?," IJERPH, MDPI, vol. 19(16), pages 1-11, August.
    2. Szymon Mućka & Martyna Miodońska & Grzegorz K. Jakubiak & Monika Starzak & Grzegorz Cieślar & Agata Stanek, 2022. "Endothelial Function Assessment by Flow-Mediated Dilation Method: A Valuable Tool in the Evaluation of the Cardiovascular System," IJERPH, MDPI, vol. 19(18), pages 1-16, September.
    3. Marek Zak & Tomasz Sikorski & Magdalena Wasik & Daniel Courteix & Frederic Dutheil & Waldemar Brola, 2022. "Frailty Syndrome—Fall Risk and Rehabilitation Management Aided by Virtual Reality (VR) Technology Solutions: A Narrative Review of the Current Literature," IJERPH, MDPI, vol. 19(5), pages 1-12, March.
    4. Grzegorz K. Jakubiak & Natalia Pawlas & Grzegorz Cieślar & Agata Stanek, 2021. "Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes," IJERPH, MDPI, vol. 18(22), pages 1-23, November.
    5. Kyoung-Hee Cho & Juyeong Kim & Young Choi & Tae-Hyun Kim, 2022. "The Effect of Neighborhood Deprivation on Mortality in Newly Diagnosed Diabetes Patients: A Countrywide Population-Based Korean Retrospective Cohort Study, 2002–2013," IJERPH, MDPI, vol. 19(7), pages 1-14, April.
    6. Carlos Farinha & Hélder Santos & João Serrano & Bárbara Oliveiros & Fernanda M. Silva & Márcio Cascante-Rusenhack & Ana Maria Teixeira & José Pedro Ferreira, 2022. "The Impact of Aquatic Exercise Programs on the Intima-Media thickness of the Carotid Arteries, Hemodynamic Parameters, Lipid Profile and Chemokines of Community-Dwelling Older Persons: A Randomized Co," IJERPH, MDPI, vol. 19(6), pages 1-17, March.
    7. Katarzyna Kaniewska & Anna Kuryliszyn-Moskal & Anna Hryniewicz & Diana Moskal-Jasińska & Mariusz Wojciuk & Zofia Dzięcioł-Anikiej, 2022. "Static Foot Disturbances and the Quality of Life of Older Person with Rheumatoid Arthritis," IJERPH, MDPI, vol. 19(14), pages 1-13, July.
    8. Chengcheng Liu & Yao Li & Jing Li & Chenggang Jin & Deping Zhong, 2022. "The Effect of Psychological Burden on Dyslipidemia Moderated by Greenness: A Nationwide Study from China," IJERPH, MDPI, vol. 19(21), pages 1-16, November.
    9. Hsin-Ya Kuo & Chih-Sung Liang & Shih-Jen Tsai & Tzeng-Ji Chen & Che-Sheng Chu & Mu-Hong Chen, 2022. "Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study," IJERPH, MDPI, vol. 19(14), pages 1-9, July.
    10. Xunjie Cheng & Tianqi Ma & Feiyun Ouyang & Guogang Zhang & Yongping Bai, 2022. "Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018," IJERPH, MDPI, vol. 19(8), pages 1-12, April.
    11. Piotr Rola & Jan Jakub Kulczycki & Adrian Włodarczak & Mateusz Barycki & Szymon Włodarczak & Marek Szudrowicz & Łukasz Furtan & Artur Jastrzębski & Maciej Pęcherzewski & Maciej Lesiak & Adrian Doroszk, 2022. "Intravascular Lithotripsy as a Novel Treatment Method for Calcified Unprotected Left Main Diseases—Comparison to Rotational Atherectomy—Short-Term Outcomes," IJERPH, MDPI, vol. 19(15), pages 1-12, July.
    12. Monika Starzak & Agata Stanek & Grzegorz K. Jakubiak & Armand Cholewka & Grzegorz Cieślar, 2022. "Arterial Stiffness Assessment by Pulse Wave Velocity in Patients with Metabolic Syndrome and Its Components: Is It a Useful Tool in Clinical Practice?," IJERPH, MDPI, vol. 19(16), pages 1-14, August.
    13. Chen-Chih Chu & Yong-Chen Chen & Ming-Hsun Lin & Wen-Tung Wu & Feng-Cheng Liu & Hsiang-Cheng Chen & Yu-Ching Chou & Chien-An Sun, 2022. "Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study," IJERPH, MDPI, vol. 19(6), pages 1-9, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:3:p:2388-:d:1050359. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.